SOTIO Biotech doses first subject in Phase I solid tumour treatment trial

Retrieved on: 2024-05-29 16:45:17

Tags for this article:

Click the tags to see associated articles and topics

SOTIO Biotech doses first subject in Phase I solid tumour treatment trial. View article details on hiswai:

Excerpt

SOTIO Biotech has dosed the first subject in its Phase I trial of SOT201 to potentially treat patients with advanced solid tumours.

Article found on: www.clinicaltrialsarena.com